Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Fibroblasts"" wg kryterium: Temat


Tytuł:
Vasopressin Receptor Type-2 Mediated Signaling in Renal Cell Carcinoma Stimulates Stromal Fibroblast Activation.
Autorzy:
Jamadar A; Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Dwivedi N; Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Mathew S; Department of Pharmaceutical Sciences, School of Pharmacy, North Dakota State University, Fargo, ND 58105, USA.
Calvet JP; Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Thomas SM; Department of Otolaryngology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Rao R; Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.; Department of Medicine, 5040 WHE, The Jared Grantham Kidney Institute, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jul 09; Vol. 23 (14). Date of Electronic Publication: 2022 Jul 09.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*/drug effects
Cancer-Associated Fibroblasts*/metabolism
Carcinoma, Renal Cell*/genetics
Carcinoma, Renal Cell*/metabolism
Carcinoma, Renal Cell*/pathology
Kidney Neoplasms*/genetics
Kidney Neoplasms*/metabolism
Kidney Neoplasms*/pathology
Receptors, Vasopressin*/genetics
Receptors, Vasopressin*/metabolism
Animals ; Antidiuretic Hormone Receptor Antagonists/pharmacology ; Cell Line, Tumor ; Culture Media, Conditioned ; Fibroblasts/metabolism ; Humans ; Kidney/drug effects ; Kidney/metabolism ; Mice ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/physiology ; Vasopressins/genetics ; Vasopressins/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expression.
Autorzy:
Walterskirchen N; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Müller C; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Ramos C; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Zeindl S; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Stang S; Institute of Medical Genetics, Medical University of Vienna, Waehringer Straße 10, A-1090, Vienna, Austria.
Herzog D; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Sachet M; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Schimek V; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Unger L; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Gerakopoulos V; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Hengstschläger M; Institute of Medical Genetics, Medical University of Vienna, Waehringer Straße 10, A-1090, Vienna, Austria.
Bachleitner-Hofmann T; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Bergmann M; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Dolznig H; Institute of Medical Genetics, Medical University of Vienna, Waehringer Straße 10, A-1090, Vienna, Austria. Electronic address: .
Oehler R; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2022 Aug 01; Vol. 540, pp. 215737. Date of Electronic Publication: 2022 May 13.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Colorectal Neoplasms*/pathology
Cell Movement/genetics ; Cell Proliferation/genetics ; Fibroblasts/metabolism ; Humans ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors.
Autorzy:
Mostafavi S; Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, 14115-154, Tehran, Iran. .
Zalpoor H; Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Hassan ZM; Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, 14115-154, Tehran, Iran. hasan_.
Pokaż więcej
Źródło:
Cellular & molecular biology letters [Cell Mol Biol Lett] 2022 Jul 22; Vol. 27 (1), pp. 58. Date of Electronic Publication: 2022 Jul 22.
Typ publikacji:
Letter
MeSH Terms:
Cancer-Associated Fibroblasts*
Metformin*/metabolism
Metformin*/pharmacology
Metformin*/therapeutic use
Neoplasms*/metabolism
Fibroblasts/metabolism ; Glycolysis ; Humans ; Lactates/metabolism ; Tumor Microenvironment
Opinia redakcyjna
Tytuł:
Upregulation of Nox4 induces a pro-survival Nrf2 response in cancer-associated fibroblasts that promotes tumorigenesis and metastasis, in part via Birc5 induction.
Autorzy:
Mir S; Department of Biochemistry and Molecular Biology, Buffett Cancer Center, College of Medicine, University of Nebraska Medical Center, 7005 Durham Research Center, 985870 Nebraska Medical Center, Omaha, NE, 68198, USA.
Golden BDO; Department of Biochemistry and Molecular Biology, Buffett Cancer Center, College of Medicine, University of Nebraska Medical Center, 7005 Durham Research Center, 985870 Nebraska Medical Center, Omaha, NE, 68198, USA.
Griess BJ; Department of Biochemistry and Molecular Biology, Buffett Cancer Center, College of Medicine, University of Nebraska Medical Center, 7005 Durham Research Center, 985870 Nebraska Medical Center, Omaha, NE, 68198, USA.
Vengoji R; Department of Biochemistry and Molecular Biology, Buffett Cancer Center, College of Medicine, University of Nebraska Medical Center, 7005 Durham Research Center, 985870 Nebraska Medical Center, Omaha, NE, 68198, USA.
Tom E; Department of Biochemistry and Molecular Biology, Buffett Cancer Center, College of Medicine, University of Nebraska Medical Center, 7005 Durham Research Center, 985870 Nebraska Medical Center, Omaha, NE, 68198, USA.
Kosmacek EA; Department of Biochemistry and Molecular Biology, Buffett Cancer Center, College of Medicine, University of Nebraska Medical Center, 7005 Durham Research Center, 985870 Nebraska Medical Center, Omaha, NE, 68198, USA.
Oberley-Deegan RE; Department of Biochemistry and Molecular Biology, Buffett Cancer Center, College of Medicine, University of Nebraska Medical Center, 7005 Durham Research Center, 985870 Nebraska Medical Center, Omaha, NE, 68198, USA.
Talmon GA; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Band V; Department of Genetics, Cell Biology and Anatomy, Buffett Cancer Center, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Teoh-Fitzgerald ML; Department of Biochemistry and Molecular Biology, Buffett Cancer Center, College of Medicine, University of Nebraska Medical Center, 7005 Durham Research Center, 985870 Nebraska Medical Center, Omaha, NE, 68198, USA. .
Pokaż więcej
Źródło:
Breast cancer research : BCR [Breast Cancer Res] 2022 Jul 14; Vol. 24 (1), pp. 48. Date of Electronic Publication: 2022 Jul 14.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Breast Neoplasms*/pathology
Cancer-Associated Fibroblasts*/pathology
Animals ; Carcinogenesis/metabolism ; Cell Line, Tumor ; Female ; Fibroblasts/metabolism ; Humans ; Mice ; NADPH Oxidase 4/genetics ; NADPH Oxidase 4/metabolism ; NF-E2-Related Factor 2/genetics ; NF-E2-Related Factor 2/metabolism ; Reactive Oxygen Species/metabolism ; Survivin/metabolism ; Up-Regulation
Czasopismo naukowe
Tytuł:
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation.
Autorzy:
Romano V; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Ruocco MR; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Carotenuto P; TIGEM, Telethon Institute of Genetics and Medicine, 80078 Naples, Italy.; Medical Genetics, Department of Translational Medical Science, University of Naples Federico II, 80131 Naples, Italy.
Barbato A; TIGEM, Telethon Institute of Genetics and Medicine, 80078 Naples, Italy.
Venuta A; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Acampora V; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
De Lella S; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Vigliar E; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Iaccarino A; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Troncone G; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Calì G; IEOS Istituto di Endocrinologia e Oncologia Sperimentale 'G. Salvatore', National Council of Research, 80131 Naples, Italy.
Insabato L; Anatomic Pathology Unit, Department of Advanced Biomedical Sciences, School of Medicine, University of Naples Federico II, 80131 Naples, Italy.
Russo D; Anatomic Pathology Unit, Department of Advanced Biomedical Sciences, School of Medicine, University of Naples Federico II, 80131 Naples, Italy.
Franco B; TIGEM, Telethon Institute of Genetics and Medicine, 80078 Naples, Italy.; Medical Genetics, Department of Translational Medical Science, University of Naples Federico II, 80131 Naples, Italy.; Scuola Superiore Meridionale, School for Advanced Studies, 80138 Naples, Italy.
Masone S; Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.
Velotti N; Department of Advanced Biochemical Sciences, University of Naples Federico II, 80131 Naples, Italy.
Accurso A; Department of General, Oncological, Bariatric and Endocrine-Metabolic Surgery, University of Naples Federico II, 80131 Naples, Italy.
Pellegrino T; DAI Chirurgia Generale, Endocrinologia, Ortopedia e Riabilitazione, Azienda Ospedaliera Universitaria Federico II, 80131 Naples, Italy.
Fiume G; Department of Experimental and Clinical Medicine, University 'Magna Graecia' of Catanzaro, 88100 Catanzaro, Italy.
Belviso I; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Montagnani S; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Avagliano A; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Arcucci A; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jun 20; Vol. 23 (12). Date of Electronic Publication: 2022 Jun 20.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/metabolism
Cancer-Associated Fibroblasts*/metabolism
Cell Line, Tumor ; Culture Media, Conditioned/metabolism ; Cyclooxygenase 2/genetics ; Cyclooxygenase 2/metabolism ; Female ; Fibroblasts/metabolism ; Humans ; Inflammation/pathology ; Stromal Cells/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer.
Autorzy:
Muchlińska A; Laboratory of Translational Oncology, Intercollegiate Faculty of Biotechnology, Medical University of Gdansk, 80-211, Gdansk, Poland.
Nagel A; Laboratory of Translational Oncology, Intercollegiate Faculty of Biotechnology, Medical University of Gdansk, 80-211, Gdansk, Poland.
Popęda M; Laboratory of Translational Oncology, Intercollegiate Faculty of Biotechnology, Medical University of Gdansk, 80-211, Gdansk, Poland.
Szade J; Department of Pathomorphology, Medical University of Gdansk, 80-214, Gdansk, Poland.
Niemira M; Clinical Research Centre, Medical University of Bialystok, 15-276, Bialystok, Poland.
Zieliński J; Department of Surgical Oncology, Medical University of Gdansk, 80-214, Gdansk, Poland.
Skokowski J; Department of Surgical Oncology, Medical University of Gdansk, 80-214, Gdansk, Poland.; Biobanking and Biomolecular Resources Research Infrastructure Poland (BBMRI.PL), 80-211, Gdansk, Poland.
Bednarz-Knoll N; Laboratory of Translational Oncology, Intercollegiate Faculty of Biotechnology, Medical University of Gdansk, 80-211, Gdansk, Poland.
Żaczek AJ; Laboratory of Translational Oncology, Intercollegiate Faculty of Biotechnology, Medical University of Gdansk, 80-211, Gdansk, Poland. .
Pokaż więcej
Źródło:
Cellular & molecular biology letters [Cell Mol Biol Lett] 2022 Jun 11; Vol. 27 (1), pp. 45. Date of Electronic Publication: 2022 Jun 11.
Typ publikacji:
Letter
MeSH Terms:
Breast Neoplasms*/pathology
Cancer-Associated Fibroblasts*/chemistry
Cancer-Associated Fibroblasts*/metabolism
Cancer-Associated Fibroblasts*/pathology
Actins/metabolism ; Cell Line, Tumor ; Culture Media, Conditioned/pharmacology ; Female ; Fibroblasts/metabolism ; Humans ; Muscle, Smooth/chemistry ; Muscle, Smooth/metabolism ; Muscle, Smooth/pathology ; Osteopontin/genetics ; Osteopontin/metabolism
Opinia redakcyjna
Tytuł:
CRMP2 derived from cancer associated fibroblasts facilitates progression of ovarian cancer via HIF-1α-glycolysis signaling pathway.
Autorzy:
Jin Y; Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China.; Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226001, China.
Bian S; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226001, China.
Wang H; Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China.
Mo J; Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China.
Fei H; Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China.
Li L; Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226001, China.
Chen T; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200040, China. .
Jiang H; Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China. .
Pokaż więcej
Źródło:
Cell death & disease [Cell Death Dis] 2022 Aug 04; Vol. 13 (8), pp. 675. Date of Electronic Publication: 2022 Aug 04.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Ovarian Neoplasms*/pathology
Animals ; Carcinoma, Ovarian Epithelial/metabolism ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Female ; Fibroblasts/metabolism ; Glycolysis ; Humans ; Intercellular Signaling Peptides and Proteins ; Mice ; Nerve Tissue Proteins ; Signal Transduction ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Pancreatic tumor eradication via selective Pin1 inhibition in cancer-associated fibroblasts and T lymphocytes engagement.
Autorzy:
Liu J; Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Thyroid and Parathyroid diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.; Respiratory Health Institute, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Wang Y; Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
Mu C; Department of Liver Surgery & Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China.
Li M; Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.; Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Bioland Laboratory, Guangzhou, China.
Li K; Department of Pediatric Department, West China Hospital, Sichuan University, Chengdu, China.
Li S; Department of Hepatobiliary Surgery, Daping Hospital, Army Medical University, Chongqing, China.
Wu W; Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Thyroid and Parathyroid diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Du L; Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
Zhang X; Department of Liver Surgery & Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China.
Li C; Department of Liver Surgery & Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China.
Peng W; Department of Liver Surgery & Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China.
Shen J; Department of Liver Surgery & Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China.
Liu Y; Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Thyroid and Parathyroid diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Yang D; Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.
Zhang K; Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Thyroid and Parathyroid diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Ning Q; Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.; Laboratory of Thyroid and Parathyroid diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Fu X; Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.
Zeng Y; Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.
Ni Y; Respiratory Health Institute, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Zhou Z; Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.
Liu Y; Department of Rheumatology and Immunology, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China.
Hu Y; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Zheng X; Department of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu, China. .
Wen T; Department of Liver Surgery & Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China. .
Li Z; Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, China. .; Laboratory of Thyroid and Parathyroid diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. .
Liu Y; Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Jul 25; Vol. 13 (1), pp. 4308. Date of Electronic Publication: 2022 Jul 25.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*/pathology
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/pathology
Cell Line, Tumor ; Fibroblasts/pathology ; Humans ; NIMA-Interacting Peptidylprolyl Isomerase/genetics ; Tumor Microenvironment
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Tytuł:
Interleukin-8 produced from cancer-associated fibroblasts suppresses proliferation of the OCUCh-LM1 cancer cell line.
Autorzy:
Tanaka R; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abenoku, Osaka, 545-8585, Japan.; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
Kimura K; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abenoku, Osaka, 545-8585, Japan. .
Eguchi S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abenoku, Osaka, 545-8585, Japan.
Ohira G; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abenoku, Osaka, 545-8585, Japan.
Tanaka S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abenoku, Osaka, 545-8585, Japan.
Amano R; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abenoku, Osaka, 545-8585, Japan.
Tanaka H; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Yashiro M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.
Ohira M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kubo S; Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abenoku, Osaka, 545-8585, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Jul 08; Vol. 22 (1), pp. 748. Date of Electronic Publication: 2022 Jul 08.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Carcinoma, Pancreatic Ductal*/pathology
Pancreatic Neoplasms*/pathology
Cell Line ; Cell Line, Tumor ; Cell Proliferation ; Fibroblasts/metabolism ; Humans ; Interleukin-8/metabolism ; Retrospective Studies ; Tumor Microenvironment
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Tytuł:
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer.
Autorzy:
Huang H; Department of Surgery, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA. Electronic address: .
Wang Z; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
Zhang Y; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA; Cancer Biology Graduate Program, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA.
Pradhan RN; Genentech, South San Francisco, CA 94080, USA.
Ganguly D; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA; Cancer Biology Graduate Program, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA.
Chandra R; Department of Surgery, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA.
Murimwa G; Department of Surgery, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA.
Wright S; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA.
Gu X; Department of Molecular Biology, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA.
Maddipati R; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA; Department of Internal Medicine, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA.
Müller S; Genentech, South San Francisco, CA 94080, USA.
Turley SJ; Genentech, South San Francisco, CA 94080, USA.
Brekken RA; Department of Surgery, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA; Cancer Biology Graduate Program, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA; Department of Pharmacology, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX 75390, USA. Electronic address: .
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2022 Jun 13; Vol. 40 (6), pp. 656-673.e7. Date of Electronic Publication: 2022 May 05.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Pancreatic Neoplasms*/pathology
Fibroblasts ; Humans ; T-Lymphocytes, Regulatory ; Transforming Growth Factor beta/metabolism
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Tytuł:
Deletion of IKKβ in activated fibroblasts promotes tumor progression in melanoma.
Autorzy:
Zhang S; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Harada M; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kimura T; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ashida N; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: .
Pokaż więcej
Źródło:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2022 Sep 17; Vol. 621, pp. 46-52. Date of Electronic Publication: 2022 Jul 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Melanoma*/pathology
Animals ; Fibroblasts/metabolism ; I-kappa B Kinase/genetics ; I-kappa B Kinase/metabolism ; Mice ; NF-kappa B/metabolism ; Protein Serine-Threonine Kinases ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Cancer-associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of ADAM9.
Autorzy:
Ao T; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Mochizuki S; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Kajiwara Y; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Yonemura K; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Shiraishi T; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Nagata K; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Shinto E; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Okamoto K; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Nearchou IP; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Shimazaki H; Department of Laboratory Medicine, National Defence Medical College, Tokorozawa, Japan.
Kishi Y; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Okada Y; Department of Pathophysiology for Locomotive and Neoplastic Diseases, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ueno H; Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2022 May 15; Vol. 150 (10), pp. 1706-1721. Date of Electronic Publication: 2022 Feb 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Colorectal Neoplasms*/metabolism
ADAM Proteins ; Animals ; Fibroblasts/pathology ; Humans ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Mice ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
The lactate-NAD axis activates cancer-associated fibroblasts by downregulating p62.
Autorzy:
Linares JF; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Cid-Diaz T; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Duran A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Osrodek M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Martinez-Ordoñez A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Reina-Campos M; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Kuo HH; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Elemento O; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Martin ML; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Cordes T; Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA.
Thompson TC; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Metallo CM; Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA; Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Moscat J; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: .
Diaz-Meco MT; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: .
Pokaż więcej
Źródło:
Cell reports [Cell Rep] 2022 May 10; Vol. 39 (6), pp. 110792.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Neoplasms*/metabolism
Fibroblasts/metabolism ; Lactic Acid/metabolism ; NAD/metabolism ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerases/metabolism
Czasopismo naukowe
Tytuł:
Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts.
Autorzy:
Mezawa Y; Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, Japan.
Orimo A; Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
The FEBS journal [FEBS J] 2022 May; Vol. 289 (9), pp. 2429-2447. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Carcinoma*/metabolism
Fibroblasts/metabolism ; Humans ; Phenotype ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
Crosstalk of tumor stromal cells orchestrates invasion and spreading of gastric cancer.
Autorzy:
Tanaka M; Department of Molecular Medicine and Biochemistry, Akita University Graduate School of Medicine, Akita, Japan.
Pokaż więcej
Źródło:
Pathology international [Pathol Int] 2022 Apr; Vol. 72 (4), pp. 219-233. Date of Electronic Publication: 2022 Feb 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Stomach Neoplasms*/pathology
Cell Line, Tumor ; Fibroblasts/pathology ; Humans ; Stromal Cells/pathology ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial-mesenchymal transition reversion.
Autorzy:
Guo J; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.; Jiangsu Province Academy of Traditional Chinese Medicine, 100 Shizi Road, Nanjing, 210028, China.; Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, Engineering Technology Research Center of Modern Pharmaceutical Preparation, College of Pharmacy, Anhui University of Chinese Medicine, 230012, Hefei, China.
Zeng H; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.
Shi X; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.
Han T; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.
Liu Y; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.
Liu Y; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.; Jiangsu Province Academy of Traditional Chinese Medicine, 100 Shizi Road, Nanjing, 210028, China.
Liu C; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.; Jiangsu Province Academy of Traditional Chinese Medicine, 100 Shizi Road, Nanjing, 210028, China.
Qu D; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China. .; Jiangsu Province Academy of Traditional Chinese Medicine, 100 Shizi Road, Nanjing, 210028, China. .
Chen Y; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China. .; Jiangsu Province Academy of Traditional Chinese Medicine, 100 Shizi Road, Nanjing, 210028, China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2022 Mar 05; Vol. 20 (1), pp. 114. Date of Electronic Publication: 2022 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Alkaloids ; Animals ; Cell Line, Tumor ; Epithelial-Mesenchymal Transition/physiology ; Fibroblasts/metabolism ; Humans ; Mice ; Peptides/metabolism ; Peptides/pharmacology ; Quinolizines ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression.
Autorzy:
Lee KW; Department of Health Science and Technology, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, 06351, Republic of Korea.
Yeo SY; Department of Health Science and Technology, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, 06351, Republic of Korea.
Gong JR; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Koo OJ; ToolGen Inc., Gasan digital 1-ro, Geumcheon, Seoul, 08594, Republic of Korea.
Sohn I; Arontier Inc., Gangnam-daero, Seoul, Republic of Korea.
Lee WY; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim HC; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Yun SH; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cho YB; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Choi MA; Department of Health Science and Technology, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, 06351, Republic of Korea.
An S; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Kim J; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.
Sung CO; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. .
Cho KH; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea. .
Kim SH; Department of Health Science and Technology, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, 06351, Republic of Korea. .; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. .; Single Cell Network Research Center, Sungkyunkwan University School of Medicine, Suwon, Gyeonggi-do, 16419, Republic of Korea. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 May 19; Vol. 13 (1), pp. 2793. Date of Electronic Publication: 2022 May 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Neoplasms*/metabolism
Animals ; Fibroblasts/metabolism ; Mice ; Myofibroblasts ; Transcription Factors/genetics ; Transcription Factors/metabolism
Czasopismo naukowe
Tytuł:
Microfluidic one-directional interstitial flow generation from cancer to cancer associated fibroblast.
Autorzy:
Kim J; School of Mechanical Engineering, Korea University, Seoul, 02841, Korea; George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, United States.
Park H; School of Mechanical Engineering, Korea University, Seoul, 02841, Korea.
Kim H; School of Mechanical Engineering, Korea University, Seoul, 02841, Korea; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, United States.
Kim Y; George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, United States; Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, United States; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, United States; Institute for Electronics and Nanotechnology, Georgia Institute of Technology, Atlanta, GA 30332, United States.
Oh HJ; School of Mechanical Engineering, Korea University, Seoul, 02841, Korea. Electronic address: .
Chung S; School of Mechanical Engineering, Korea University, Seoul, 02841, Korea; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Korea. Electronic address: .
Pokaż więcej
Źródło:
Acta biomaterialia [Acta Biomater] 2022 May; Vol. 144, pp. 258-265. Date of Electronic Publication: 2022 Mar 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Neoplasms*/pathology
Cell Line, Tumor ; Fibroblasts/metabolism ; Humans ; Hydrogels/metabolism ; Microfluidics ; Tumor Microenvironment/physiology ; Vimentin/metabolism
Czasopismo naukowe
Tytuł:
Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusions.
Autorzy:
Ito M; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Nakano M; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Ariyama H; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Yamaguchi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Tanaka R; Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan.
Semba Y; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Sugio T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Miyawaki K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Kikushige Y; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Mizuno S; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Isobe T; Department of Oncology and Social Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tanoue K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Taguchi R; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Ueno S; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Kawano T; Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan.
Murata M; Center for Advanced Medical Innovation, Kyushu University, Fukuoka, Japan.
Baba E; Department of Oncology and Social Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: .
Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2022 Apr 28; Vol. 532, pp. 215597. Date of Electronic Publication: 2022 Feb 10.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Peritoneal Neoplasms*/metabolism
Pleural Effusion*/metabolism
Pleural Effusion*/pathology
Animals ; Ascites/metabolism ; Cell Adhesion Molecules/metabolism ; Cell Line, Tumor ; Cell Proliferation ; Fibroblasts/metabolism ; Humans ; Macrophages ; Mice ; Thy-1 Antigens/metabolism ; Transforming Growth Factor beta/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Activation of Fibroblasts in Skin Cancer.
Autorzy:
Van Hove L; VIB Center for Inflammation Research, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium; Cancer Research Institute Ghent, Ghent University, Ghent, Belgium.
Hoste E; VIB Center for Inflammation Research, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium; Cancer Research Institute Ghent, Ghent University, Ghent, Belgium. Electronic address: .
Pokaż więcej
Źródło:
The Journal of investigative dermatology [J Invest Dermatol] 2022 Apr; Vol. 142 (4), pp. 1026-1031. Date of Electronic Publication: 2021 Sep 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Skin Neoplasms*/pathology
Fibroblasts/metabolism ; Humans ; Transcriptome ; Tumor Microenvironment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz